Clinical Trial Update: Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes

View source ↗

Summary

An update on a completed clinical trial assessing GLP-1 effects on alpha-cell sensitivity in people with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Copenhagen | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED